Ventria Bioscience Initiates Seventh Straight Year of Production
Plant-made pharmaceutical company developing health solutions for the global community.
Maryville, MO (PRWEB via PR Web
Direct) December 23, 2004 -- Ventria Bioscience has submitted its 2005
production permit application to the United States Department of Agriculture,
thus initiating the company’s seventh straight year of production and
development of products, including an improved oral rehydration solution that
incorporates two of Ventria’s proteins. Oral rehydration solutions are
administered to children with acute diarrhea, which claims the lives of 1.3
million children annually.
Ventria has received approval from the USDA
every year since 1999 to produce crops for plant-made pharmaceuticals. The 2005
permits would authorize production in Cape Girardeau, Scott and Mississippi
counties in Missouri. In November the company announced plans to move its
operations to Missouri in order to take advantage of a partnership with
Northwest Missouri State University.
"Ventria is dedicated to leading the
development of plant-made pharmaceuticals that promise affordable human health
products for the global community," said Scott Deeter, President and CEO of
Ventria Bioscience. "We are committed to product quality and best practices that
will set the industry standard. Ventria’s permits, which are submitted according
to federal regulation as a normal part of our operations, describe the
production practices to be followed during the company’s production operations,"
he continued.
In order to maintain product quality and as part of
Ventria’s commitment to sound stewardship, Ventria has instituted the following
production practices:
• Ventria’s field production is
separated from the nearest commodity rice or barley production by more than five
miles;
• Ventria’s products are manufactured within the
seed of self-pollinating rice or barley, which are not wind or insect pollinated
plants;
• Ventria’s field production, storage, grinding and
transportation equipment is dedicated only to Ventria’s use and is not used for
any commodity rice or barley production.
• Ventria’s
contractors and field production personnel receive extensive training related to
regulatory requirements and Ventria’s standard operating procedures.
• Ventria monitors its production practices for compliance
and performs frequent audits of its operations.
"Ventria’s track record
of working with the USDA is impeccable," said State Sen. David Klindt, R-12th
District, chairman of the Missouri Senate agriculture committee. "They have
proven year after year that they understand the importance of working with the
USDA to assure regulatory compliance and industry best practices."
Klindt
pointed to the company’s record of success in achieving USDA permits and having
passed every inspection over the past six years, including eight inspections
during its 2004 production season in California and Iowa. "Ventria certainly
adds to Missouri’s economic development success in attracting leading life
science research and companies to the state," said Klindt.
Ventria
Bioscience is committed to developing affordable human health products that
enhance and save lives. Ventria’s proteins and peptides are manufactured in the
seed of self-pollinating plants using ExpressTec, a proprietary technology that
has achieved unrivaled efficiency for the production of proteins and peptides
for human and animal health products.
For more information, see our
website at Ventria Bioscience http://www.ventria.com.
Or contact:
Brandy Sargent,
Corporate Communications
e-mail protected from spam bots
(916)
921-6148
State Sen. David Klindt
(573) 751-1415
# # #
Source : http://www.prweb.com/releases/2004/12/prweb191613.htm